To get the best results with semaglutide, it helps to pay close attention to sugar intake
Reddy's Laboratories, making Canada the first G7 country to approve a generic version of semaglutide [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]
Common experiences include losing interest in foods previously enjoyed, feeling uncomfortably full after much smaller meals, reduced snacking urges throughout the day, and diminished cravings for sweets or salty foods
November 8, 2005
The researchers caution that prospective studies are needed before an individualized approach can be incorporated into routine clinical practice, but say their findings represent an important step toward more precise treatment for obesity
Thats why we ended the partnership. In a post on X, Hims Chief Executive Andrew Dudum called the Novo executives comments misleading. He said Novo had been pressuring Hims to steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to be strong-armed, he said, adding that Hims will continue to offer a range of treatments, including Wegovy. Hims shares tumbled 35% in New York Monday the most ever as analysts said the withdrawal would leave the telehealth company without an attractive obesity profit stream